Sodhi said he hopes the drug makers of GLP-1 agonists will consider updating the warning labels of their products, which currently dont include the risk of gastroparesis
At Vitality Aesthetic Solutions, we provide personalized guidance and ongoing support to help ensure you achieve the best possible results throughout your treatment journey
Video above: Could popular weight loss drugs treat addiction
That's what patients who take Novo Nordisk's Rybelsus, a pill form of semaglutide, have to do, according to Siegel
The results suggested that at week 12 after treatment discontinuation, there was no significant difference in weight regain between significant and not significant weight loss subgroup ( P = 0.99) (Additional file 2: Fig
PubMed laboratory research record [PMID: 3004921] PubMed record related to this compound for laboratory literature review